Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-08-04

Clinical Trial Update: A Pharmacodynamic/Pharmacokinetic Study to Determine the Onset of Analgesic Effect and Plasma Levels of Tramadol in Patients With Acute Low Back Pain Receiving a Single 200 mg Dose of Tramadol Contramid® Once-a-Day [Phase 2]

View source ↗

Summary

This Phase 2 pharmacodynamic/pharmacokinetic study evaluated the onset of analgesia and plasma levels after a single 200 mg dose of Tramadol Contramid, given on…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tramadol Contramid (tramadol)

Snippet

Sponsor: Labopharm Inc. | Conditions: Acute Low Back Pain | Phase 2 | Status: COMPLETED | Results posted: 2009-08-04